Tom Wilemon Archive
-
February 5, 2020
Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report
Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer. -
February 5, 2020
Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform. -
January 16, 2020
Journey Home Project supports first CAR-T infusion at VA hospital
The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville. -
January 9, 2020
Park named interim Hematology and Oncology director
Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology. -
January 9, 2020
Impact of weight gain from early to middle adulthood explored
An analysis of weight gain occurring from early to middle adulthood indicates that the added weight is associated with multiple health outcomes in later life. -
December 12, 2019
Richmond receives legacy award from Society for Leukocyte Biology
Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.